- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05847933
Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance (SAME)
November 28, 2023 updated by: Prof. Dominique de Quervain, MD
A Pilot Study on the Influence of Temporo-occipital Transcranial Magnetic Brain Stimulation on Aversive Episodic Memory Performance
A pilot study, examining the effect of repeated transcranial magnetic brain stimulation (rTMS) on the formation of memories with negative valence.
The investigators hypothesize that an effective rTMS protocol to reduce memory performance for adverse events can be found.
Study Overview
Status
Recruiting
Conditions
Study Type
Interventional
Enrollment (Estimated)
105
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Ehssan Amini, MD
- Phone Number: +41 61 207 02 26
- Email: ehssan.amini@unibas.ch
Study Locations
-
-
BS
-
Basel, BS, Switzerland, 4055
- Recruiting
- University of Basel, Division of Cognitive Neuroscience
-
Contact:
- Dominique de Quervain, Prof.
- Phone Number: 061 207 02 37
- Email: dominique.dequervain@unibas.ch
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Male or female
- Generally healthy
- Normotensive (BP 90/60mmHg - 140/90mmHg)
- BMI: 19 - 30 kg/m2
- Age: 18 - 30 years
- Fluent German-speaking
Exclusion Criteria:
- Metal in the brain, skull or elsewhere in the body (e.g., splinters, fragments, clips, etc.)
- Implanted neurostimulator (e.g., DBS, epidural/subdural, VNS)
- Cardiac pacemaker or intracardiac lines
- Medication infusion device
- Nonremovable Piercings in the head area, pivot teeth (retainers are no exclusion criterion)
- Tattoos (head area) less than 3 months old or older than 20 years
- Condition after neurosurgery
- Hearing problems or tinnitus
- Not able to sit still due to tremor, tics, itching
- History of repeated syncope
- Head trauma diagnosed as concussion or associated with loss of consciousness
- diagnosis of epilepsy, or a convulsion or a seizure in the past of the participant or his/her close family
- TMS in the past showing problems
- Surgical procedures to spinal cord
- Spinal or ventricular derivations
- Alcohol or drug intake 48 hours before start of visits
- Regular intake of any medication or CNS-active medication 48h before visit
- rMT above the limits of rTMS device.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Sequential Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: cTBS experiment
Active brain stimulation on the inferior occipital gyrus using the cTBS protocol.
|
rTMS using cTBS protocol with the following characteristics:
|
Sham Comparator: cTBS sham
Sham brain stimulation on the inferior occipital gyrus using the cTBS protocol
|
rTMS using cTBS protocol with the following characteristics:
|
Active Comparator: cTBS active control
Active brain stimulation on the right superior frontal cortex using the cTBS protocol
|
rTMS using cTBS protocol with the following characteristics:
|
Experimental: High frequency
Active brain stimulation on the inferior occipital gyrus using the 5Hz protocol
|
rTMS using high frequency protocol with the following characteristics: Frequency: 5 Hz
|
Experimental: Low frequency
Active brain stimulation on the inferior occipital gyrus using the 1Hz protocol
|
rTMS using Low frequency protocol with the following characteristics:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
memory recall performance
Time Frame: On average 1 hour after intervention
|
The difference between valence specific (negative, positive, and neutral) memory performance as assessed by a standard picture recall episodic memory task.
|
On average 1 hour after intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Working memory performance
Time Frame: On average 1 hour after intervention
|
Working memory performance measured by n-back task
|
On average 1 hour after intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Dominique de Quervain, Prof. MD, University of Basel, Research Platform Molecular and Cognitive Neuroscience
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 6, 2023
Primary Completion (Estimated)
May 31, 2024
Study Completion (Estimated)
May 31, 2024
Study Registration Dates
First Submitted
April 14, 2023
First Submitted That Met QC Criteria
April 27, 2023
First Posted (Actual)
May 8, 2023
Study Record Updates
Last Update Posted (Actual)
November 29, 2023
Last Update Submitted That Met QC Criteria
November 28, 2023
Last Verified
November 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- 2023-00392 BASEC_Nr
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
All IPD (de-identified) that underlie results in a publication will be shared upon reasonable request
IPD Sharing Access Criteria
All IPD (de-identified) that underlie results in a publication will be shared upon reasonable request for scientific purposes.
A reasonable request consists of a short description of the scientific purpose.
Requests will be reviewed by the team of the principle investigator.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Memory, Episodic
-
Boston CollegeNot yet recruiting
-
Institut National de la Santé Et de la Recherche...University Hospital, Caen; La Région Basse-Normandie; Université de Caen Normandie and other collaboratorsCompleted
-
Northwestern UniversityRecruiting
-
Institut National de la Santé Et de la Recherche...University Hospital, Caen; La Région Basse-Normandie; Université de Caen Normandie and other collaboratorsCompleted
-
Boston CollegeNot yet recruitingHealthy | Episodic Memory
-
Stephan HamannWithdrawn
-
University Hospital, GrenobleUniversity Grenoble Alps; Laboratoire de Psychologie et NeuroCognition; Université...CompletedMemory, Episodic | Form PerceptionFrance
-
Maastricht University Medical CenterCompletedDopamine Activity | Episodic Memory Consolidation | Response PreparationNetherlands
-
Yale UniversityCompletedAlcohol Drinking | Drinking Behavior | Episodic Memory | Long-term MemoryUnited States
-
University Hospital, Strasbourg, FranceSuspended
Clinical Trials on rTMS (cTBS experiment)
-
University Hospital, GhentTerminated
-
Shanghai Mental Health CenterRenJi Hospital; Shanghai 10th People's HospitalRecruitingObsessive-Compulsive DisorderChina
-
University of Missouri-ColumbiaNot yet recruitingNicotine Dependence
-
Mclean HospitalBeth Israel Deaconess Medical CenterNot yet recruitingSchizophrenia | Schizoaffective Disorder | Psychosis | Bipolar Disorder IUnited States
-
University of MinnesotaCompletedTourette Syndrome | Tic Disorders | Tics | Tourette Syndrome in Children | Tourette Syndrome in Adolescence | Tic Disorder, Childhood | Tic, MotorUnited States
-
Universiteit AntwerpenUniversitair Ziekenhuis BrusselUnknownDepression | Mood Disorders | Bipolar Disorder | Bipolar Depression | Mental Disorder | Bipolar I Disorder | Bipolar II DisorderBelgium
-
Changping LaboratoryRecruitingAphasia | Stroke, IschemicChina
-
University of California, San DiegoCompletedCognitive ControlUnited States
-
University of ArizonaRecruitingInsomnia, PrimaryUnited States